Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Antral

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44300   clinical trials with a EudraCT protocol, of which   7354   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    42 result(s) found for: Antral. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2009-012222-36 Sponsor Protocol Number: 1.0 Start Date*: 2009-07-23
    Sponsor Name:Medizinische Universität Wien, Bernhard Gottlieb Universitätszahnklinik
    Full Title: Verification of an oro-antral communication after tooth extraction in the upper jaw. A Pilot-study
    Medical condition:
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001143-59 Sponsor Protocol Number: IVFAFC1 Start Date*: 2006-07-14
    Sponsor Name:School of Human Development
    Full Title: A prospective, randomised study comparing two fixed daily doses (150 IU versus 225 IU) of recombinant FSH for ovarian stimulation during in-vitro fertilisation treatment in predicted low and interm...
    Medical condition: Infertility needing In-Vitro fertilisation treatment
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2020-004075-41 Sponsor Protocol Number: 2020-6941 Start Date*: 2021-02-04
    Sponsor Name:Radboudumc
    Full Title: Effectiveness of Somatostatin Analogues in patients with Gastric antral vascular ectasia and symptomatic gastrointestinal bleeding: SAGAVE-Pilot study
    Medical condition: Gastric Antral Vascular Ectasia (also known as watermelon stomach)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-003492-35 Sponsor Protocol Number: MED2-201301 Start Date*: 2015-05-26
    Sponsor Name:University of Bonn
    Full Title: Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation with Dabigatran after Pulmonary Vein Isolation for Atrial Fibrillation
    Medical condition: atrial fibriallation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-002453-26 Sponsor Protocol Number: 73908 Start Date*: 2020-11-18
    Sponsor Name:Rigshospitalet
    Full Title: Eight weeks of androgen priming by hCG before IVF/ICSI in women with low ovarian reserve.
    Medical condition: Female Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016399 Female infertility (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-019287-37 Sponsor Protocol Number: FIN3001 Start Date*: 2010-08-24
    Sponsor Name:Finox AG
    Full Title: A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment
    Medical condition: Stimulation of multifollicular develoment in patients undergoing assisted reproductivet treatment
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) AT (Completed) ES (Completed) GB (Prematurely Ended) DK (Completed)
    Trial results: View results
    EudraCT Number: 2005-003104-11 Sponsor Protocol Number: 1.0 Start Date*: 2005-10-11
    Sponsor Name:Fertility clinic Odense University Hospital
    Full Title: Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response
    Medical condition: Hypothesis. By combining pituitary downregulation with aromatase inhibitor, and hCG injection during a late luteal phase a powerful stimulation of thecal androgen production is achieved. Thereby, i...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002341-30 Sponsor Protocol Number: 1705-VLC-030-JG Start Date*: 2017-09-11
    Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI)
    Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization
    Medical condition: prevent premature luteinitation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10041244 - Social circumstances 10072070 Oocyte donor PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2019-001343-44 Sponsor Protocol Number: IB-0319-002 Start Date*: 2019-05-21
    Sponsor Name:Instituto Bernabeu
    Full Title: Conventional ovarian stimulation vs. stimulation with single injection of Corifollitropin alfa in oocyte donors. Randomized clinical trial. Tail Studio
    Medical condition: Oocyte donation
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2019-000971-17 Sponsor Protocol Number: 58335 Start Date*: 2019-07-17
    Sponsor Name:UZ Brussel
    Full Title: Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study
    Medical condition: infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-000228-24 Sponsor Protocol Number: MANA2016-1 Start Date*: 2016-07-13
    Sponsor Name:UZ Brussel
    Full Title: Eradication of H. pylori infection in Belgium: bismuth versus first line therapy
    Medical condition: Patients with H. pylori infection, never treated before
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004969-40 Sponsor Protocol Number: RHFERAMH-0001 Start Date*: 2012-11-27
    Sponsor Name:Fertility Clinic, Copenhagen University Hospital, Rigshospitalet
    Full Title: An AMH based indivdualised controlled ovarian stimulation regiment using Corifollitrophin or graded doses of rFSH versus a standard protocol. A randomised controlled trial
    Medical condition: In vitro fertilization include controlled ovarian stimulation (COS), where follicles are stimulated to full maturity. One of the main problems of the IVF treatment is still to some patients deve...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004872 10021930 Infertility NOS LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-004780-71 Sponsor Protocol Number: PROFERTIL Start Date*: Information not available in EudraCT
    Sponsor Name:Karolinska University Hospital
    Full Title: A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil
    Medical condition: Breast Cancer Acute Leukemia Lymphomas (Hodgkin and non-Hodgkin) Sarcomas (Osteo, Soft tissue and Ewing)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2020-005914-16 Sponsor Protocol Number: 2019COIMBRA001 Start Date*: 2021-03-01
    Sponsor Name:Universitair Ziekenhuis Brussel
    Full Title: COmbining Interventions of fertility preservation to Mitigate fertility loss after BReAst cancer
    Medical condition: Female patients with breast cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006279 Breast neoplasm PT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002979-17 Sponsor Protocol Number: MANCOR Start Date*: 2014-01-27
    Sponsor Name:IVI Sevilla
    Full Title: Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders
    Medical condition: Low response to ovarian stimulation
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-001743-20 Sponsor Protocol Number: 1403-MAD-013-AR Start Date*: 2015-07-30
    Sponsor Name:IVI Madrid
    Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG
    Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022151-32 Sponsor Protocol Number: FUNDEX001 Start Date*: 2011-02-03
    Sponsor Name:FUNDACION SANTIAGO DEXEUS FONT
    Full Title: Ensayo clínico fase II aleatorizado de cotratamiento con hormona de crecimiento recombinante humana dentro de un protocolo largo de estimulación ovárica bajo agonista de GnRH en mujeres con pobre r...
    Medical condition: Comprobar si la adición de rGH a un tratamiento estándar de estimulación ovárica controlada mejora la respuesta ovárica en mujeres con pobre respuesta previa. Los objetivos secundarios incluyen la...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-000201-11 Sponsor Protocol Number: VLC-CB-090108-001 Start Date*: 2008-05-30
    Sponsor Name:Instituto Valenciano de Infertilidad
    Full Title: Ensayo piloto randomizado, doble-ciego, en grupos paralelos, placebo-controlado, monocéntrico evaluando la tolerabilidad de la quinagolida 200mcg/día en un régimen de aumento de dosis en donantes d...
    Medical condition: Pacientes con riesgo del Sindrome de Hiperestimulación Ovárica (SHO)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033266 Ovarian hyperstimulation syndrome LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-002425-21 Sponsor Protocol Number: 11054 Start Date*: 2012-02-10
    Sponsor Name:University of Nottingham
    Full Title: Efficacy of Dehydroepiandrosterone to overcome the effect of ovarian aging
    Medical condition: Women having low ovarian reserve undergoing IVF/ICSI treatment
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-009429-26 Sponsor Protocol Number: local 997 (P06034) Start Date*: 2010-03-15
    Sponsor Name:FREE UNIVERSITY OF BRUSSELS
    Full Title: A PILOT STUDY TO EVALUATE THE EFFECT OF TRIGGERING FINAL OOCYTE MATURATION WITH GnRHa OR hCG ON ENDOMETRIAL RECEPTIVITY PARAMETERS AND THE LUTEAL PHASE IN OOCYTE DONORS
    Medical condition: Compare the endometrium of oocyte donors, who had final oocyte maturation with either hCG, Suprefact, followed by hCG 35 hours after triggering, Suprefact or Suprefact without luteal phase support....
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA